Overview
- 5 inspections across 5 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-08-06.
At a glance
Inspections
5
Sites
5
Observations
2
Career since
Sep 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Intervet Inc. (d/b/a Merck Animal Health) | 6 Aug 2024 | Animal Drugs & Feeds | View 483 → |
| Merial Limited | 19 Dec 2019 | Animal Drugs & Feeds | |
| Boehringer Ingelheim Animal Health | 19 Dec 2019 | Animal Drugs & Feeds | |
| East Tennessee Clinical Research, Inc | 21 Mar 2019 | Animal Drugs & Feeds | On file |
| Aliri USA Inc. | 21 Sep 2018 | Animal Drugs & Feeds |
Sites inspected
Intervet Inc. (d/b/a Merck Animal Health)Rahway, United States1 insp.
Merial LimitedDuluth, United States1 insp.
Boehringer Ingelheim Animal HealthDuluth, United States1 insp.
East Tennessee Clinical Research, IncRockwood, United States1 insp.
Aliri USA Inc.Colorado Springs, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Stefanie R Cook3 shared
Vanessa E Coulter2 shared
Nicole M Bell2 shared
Jordan C Desilva1 shared
Jay B Shah1 shared
Michael Serrano1 shared
Delisa R Davis1 shared
Ann B Borromeo1 shared
Laura L Staples1 shared
Full investigator report
Get the verbatim findings behind Ana C Lazo's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site